Streetbeat News

Revenues

LFST

LifeStance Health Group, Inc. (LFST) forecasts its fiscal year 2024 revenues to be between $1.19B and $1.24B, aligning closely with the consensus estimate of $1.20B. The company also anticipates a center margin of $345M-$365M and an adjusted EBITDA of $80M-$90M, with expectations to generate positive free cash flow for the year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:16 am

YOU

Clear Secure forecasts significant growth for FY24, including strong revenue and total bookings growth, expanding margins, and at least 30% growth in free cash flow.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:12 am

IART

Integra LifeSciences projects Q1 FY2024 revenues to be between $360M-$365M, indicating a reported and organic decline of approximately -5.5% to -4.1% and -5.1% to -3.7%, respectively, falling short of the consensus estimate of $380.91M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:10 am

YOU

Clear Secure anticipates Q1 revenue to be between $172M-$174M, surpassing the estimated $164.6M. Additionally, Q1 total bookings are expected to range from $178M-$183M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:08 am

DY

Dycom Industries (NYSE:DY) reported Q4 sales of $952.46M, missing the consensus estimate of $968.87M by 1.69%. This represents a 3.81% increase over the previous year's sales of $917.47M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:07 am

IART

Integra LifeSciences projects FY 2024 revenues to be between $1.603B and $1.618B, indicating a growth of 4.0%-5.0%, which is slightly below the consensus estimate of $1.62B.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:06 am

LFST

LifeStance Health Gr reported Q4 sales of $280.60M, surpassing the $263.00M estimate, marking a 6.69% beat and a 22.34% increase from the previous year. The net loss narrowed to $(45)M from $(46.7)M a year ago.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:02 am

VIPS

Vipshop anticipates its Q1 total net revenues to grow between 0% to 5% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:04 am

ACMR

ACM Research projects its FY24 revenue to be in the range of $650M-$725M, which is in line with the consensus estimate of $693.06M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:03 am

ICL

ICL Group has acquired Nitro 1000, a Brazilian biologicals manufacturer, for $30M, expanding its product offerings and market presence in sustainable agriculture solutions.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 7:33 am